{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:17:24Z","timestamp":1791404244953,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pupt.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T10:27:42Z","timestamp":1553423262000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial"],"prefix":"10.1016","volume":"56","author":[{"given":"Henrik","family":"Watz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-3173","authenticated-orcid":false,"given":"Johannes","family":"Nagelschmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina","family":"van der Mey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiemo-Joerg","family":"Bandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pupt.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.pupt.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis","volume":"4","author":"King","year":"2009","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.pupt.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1510\/icvts.2011.284208","article-title":"Non-cystic fibrosis bronchiectasis","volume":"13","author":"Neves","year":"2011","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.pupt.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pupt.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.rppneu.2013.03.006","article-title":"New advances in the therapy of non-cystic fibrosis bronchiectasis","volume":"19","author":"Amorim","year":"2013","journal-title":"Rev. Port. Pneumol."},{"key":"10.1016\/j.pupt.2019.03.009_bib8","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","volume":"1","author":"Pizzutto","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.pupt.2019.03.009_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thx.2010.136119","article-title":"British thoracic society bronchiectasis non-CF guideline group. British thoracic society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.pupt.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.pupt.2019.03.009_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.pupt.2019.03.009_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2019.03.009_bib14","first-page":"22","article-title":"Histopathology of bronchiectasis","volume":"52","author":"Goddard","year":"2011","journal-title":"Eur. Respir. Monogr."},{"issue":"11\u201312","key":"10.1016\/j.pupt.2019.03.009_bib15","article-title":"Serine proteases of the human immune system in health and disease","volume":"47","author":"Heutinck","year":"2010","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.pupt.2019.03.009_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082794","article-title":"Inhibition of human neutrophil elastase by pentacyclic triterpenes","volume":"8","author":"Feng","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pupt.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000029463","article-title":"Neutrophil inflammation and activation in bronchiectasis: comparison with pneumonia and idiopathic pulmonary fibrosis","volume":"67","author":"Schaaf","year":"2000","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2012.12.009","article-title":"Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis","volume":"107","author":"Stockley","year":"2013","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.pupt.2019.03.009_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cmdc.201500131","article-title":"Freezing the bioactive conformation to boost potency: the identification of BAY\u200585-8501, a selective and potent inhibitor of human neutrophil elastase for pulmonary diseases","volume":"10","author":"von\u2005Nussbaum","year":"2015","journal-title":"ChemMedChem"},{"issue":"Suppl 58","key":"10.1016\/j.pupt.2019.03.009_bib20","first-page":"3416","article-title":"The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases","volume":"44","author":"Nagelschmitz","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"20","key":"10.1016\/j.pupt.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.pupt.2019.03.009_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2019.03.009_bib24","author":"US Food and Drug Administration"},{"issue":"Suppl 58","key":"10.1016\/j.pupt.2019.03.009_bib25","first-page":"P1510","article-title":"The novel elastase inhibitor BAY 85-8501: first-in-man study to evaluate safety, tolerability and pharmacokinetics in healthy male subjects","volume":"44","author":"Nagelschmitz","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"Suppl 8","key":"10.1016\/j.pupt.2019.03.009_bib26","first-page":"1511","article-title":"The novel elastase inhibitor BAY 85-8501: bioavailability and food effect study to evaluate pharmacokinetics of tablet formulations","volume":"44","author":"Nagelschmitz","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.pupt.2019.03.009_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cyto.2014.10.008","article-title":"Multi-analyte profiling of inflammatory mediators in COPD sputum\u2013the effects of processing","volume":"71","author":"Pedersen","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.rmed.2012.12.006","article-title":"HOPE-preservation of paraffin-embedded sputum samples\u2013a new way of bioprofiling in COPD","volume":"107","author":"Pedersen","year":"2013","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2019.03.009_bib29","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1172\/JCI115738","article-title":"Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line","volume":"89","author":"Nakamura","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"9842","key":"10.1016\/j.pupt.2019.03.009_bib30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pupt.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.pupt.2019.03.009_bib32","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"J. Am. Med. Assoc."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918302827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918302827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:29:23Z","timestamp":1761082163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553918302827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"alternative-id":["S1094553918302827"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2019.03.009","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}